NEW YORK (GenomeWeb News) – Decode Genetics has received another letter from the Nasdaq Stock Exchange notifying the firm that for 30 consecutive business days the market value of its publicly traded common stock was below $15 million, which is the minimum level required for continued listing on the Nasdaq Global Market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.